China AND INDIA MAKING INROADS IN BIOTECH DRUGS<br />New York Times, 18 September 2011<br />
Definitions<br />Brand-name drug = a drug that has a trade name and is protected by a patent<br />Patent = exclusive right...
Interesting points<br />How developing countries attempt to circumvent patents<br />How the pharmaceutical industry and ri...
Key takeaways<br />China and India can now copy the biotech drugs used to treat cancer, diabetes and other non-communicabl...
Why I chose this topic<br />Has a legal element<br />Reflects the need to weigh competing policy considerations<br />Ratin...
Discussion questions<br />Who will win the battle? Will developing countries be able to get the pharmaceutical industry to...
Upcoming SlideShare
Loading in …5
×

Evangeline Chee

320 views

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
320
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Evangeline Chee

  1. 1. China AND INDIA MAKING INROADS IN BIOTECH DRUGS<br />New York Times, 18 September 2011<br />
  2. 2. Definitions<br />Brand-name drug = a drug that has a trade name and is protected by a patent<br />Patent = exclusive rights to produce and sell a product<br />Generic drug = cheaper but equally effective version of brand-name drug; manufactured without a licence and after the patent has expired<br />
  3. 3. Interesting points<br />How developing countries attempt to circumvent patents<br />How the pharmaceutical industry and richer nations are fighting back<br />Similarities between the current dilemma over cancer drugs and the one over AIDS 10 years ago<br />
  4. 4. Key takeaways<br />China and India can now copy the biotech drugs used to treat cancer, diabetes and other non-communicable diseases<br />Effect<br />Pharmaceutical companies and richer countries vs developing countries<br />Reduce healthcare costs<br />
  5. 5. Why I chose this topic<br />Has a legal element<br />Reflects the need to weigh competing policy considerations<br />Rating: 8/10<br />
  6. 6. Discussion questions<br />Who will win the battle? Will developing countries be able to get the pharmaceutical industry to give up their patent rights for cancer drugs (and the accompanying profits)?<br />Who should win the battle?<br />

×